Quick Answer
LISATA THERAPEUTICS, INC. reported Total Revenue of $170.0 thousand for the year ending 2025.
- LISATA THERAPEUTICS, INC. showed a decrease of -83.0% in Total Revenue from 2024 to 2025.
- This data is from LISATA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $19.41 million | Q3 2010: $16.48 million | Q1 2011: $19.59 million | Q2 2011: $2.21 million | Q3 2011: $2.18 million | Q1 2012: $3.77 million | Q2 2012: $3.37 million | Q3 2012: $4.43 million | Q1 2013: $2.5 thousand | Q2 2013: $4.4 thousand | Q3 2013: $3.7 thousand | Q4 2013: $4.1 thousand | Q1 2014: $4.1 thousand | Q2 2014: $4.5 thousand | Q3 2014: $4.1 thousand | Q4 2014: $5.3 thousand | Q1 2015: $3.17 million | Q2 2015: $5.87 million | Q3 2015: $5.89 million | Q4 2015: $7.6 thousand | Q1 2016: $7.49 million | Q2 2016: $8.30 million | Q3 2016: $9.32 million | Q1 2017: $7.92 million | Q2 2024: $0.00 | Q3 2024: $0.00 | Q2 2025: $70.0 thousand | Q3 2025: $0.00.
- Over the full 10 years of available data (2010 to 2025), LISATA THERAPEUTICS, INC.'s Total Revenue has declined by 99.8%.
- Historical annual values: Fiscal year 2025: $170.0 thousand | Fiscal year 2024: $1.00 million | Fiscal year 2023: $0.00 | Fiscal year 2016: $35.28 million | Fiscal year 2015: $22.49 million | Fiscal year 2014: $17.94 million | Fiscal year 2013: $14.67 million | Fiscal year 2012: $14.33 million | Fiscal year 2011: $10.05 million | Fiscal year 2010: $69.82 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: